SCHEMBL5290034

SCHEMBL5290034

Cc1ccc(C(=O)Oc2c(F)c(F)c(F)c(F)c2F)s1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DAO P14920 1/20 0.50
ALDH1A1 P00352 8/20 0.44
POLB P06746 5/20 0.44
HPGD P15428 2/20 0.44
CASP3 P42574 1/20 0.44
SENP8 Q96LD8 1/20 0.44
SENP7 Q9BQF6 1/20 0.44
SENP6 Q9GZR1 1/20 0.44
RAB9A P51151 3/20 0.41
TDP1 Q9NUW8 3/20 0.40
KMT2A Q03164 3/20 0.40
RECQL P46063 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
MEN1 O00255 2/20 0.40
NPC1 O15118 2/20 0.40
APEX1 P27695 1/20 0.40
HTT P42858 1/20 0.40
BLM P54132 1/20 0.40
LMNA P02545 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5889493 0.89 HDAC4 (0.42) DAOALDH1A1POLBHPGDCASP3
SCHEMBL5889494 0.82 DAO (0.50) DAOALDH1A1POLBHPGDRAB9A
SCHEMBL28513694 0.81 CES2 (0.50) DAOALDH1A1POLBHPGDCASP3
SCHEMBL7651751 0.77 DAO (0.61) DAOALDH1A1POLBHPGDCASP3
SCHEMBL5966698 0.76 RAB9A (0.53) ALDH1A1POLBHPGDRAB9AKMT2A
SCHEMBL5889507 0.76 NPSR1 (0.41) ALDH1A1POLBHPGDRAB9AKMT2A
SCHEMBL425794 0.75 DAO (0.65) DAOALDH1A1POLBHPGDCASP3
SCHEMBL2659566 0.72 HDAC3 (0.62) DAOALDH1A1POLBHPGDCASP3
SCHEMBL2741519 0.71 DAO (0.39) DAOALDH1A1POLBHPGDCASP3
SCHEMBL15275294 0.71 ALDH1A1 (0.42) DAOALDH1A1POLBHPGDCASP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007001335-A2 RAMOPLANIN DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY VICURON PHARMACEUTICALS INC. (US) 2007-01-04 WO disclosed
US-20060211603-A1 Ramoplanin derivatives possessing antibacterial activity VICURON PHARMACEUTICALS INC. (US) 2006-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060211603-A1 Ramoplanin derivatives possessing antibacterial activity CLSPN, LMAN2, RPN2 DAO 1438/4885ALDH1A1 2972/4885POLB 3888/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.